Nuvectis Pharma, Inc. Common Stock

Go to Nuvectis Pharma, Inc. Common Stock Website

$6.60

-0.30 (-4.35%)
Live
Previous Close

$6.46

Day Range

$6.42 - $7.0099

Previous Day Range

$6.81 - $7.3696

Market Cap

$144.2 million USD

Day Vol.

170171

Previous Day Vol.

288284

Currency

USD

Primary Exchange

Nasdaq

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the d...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Nuvectis Pharma, a clinical-stage biopharmaceutical company, announced the pricing of its $13.5 million public offering of 2.7 million shares of common stock at $5 per share. The company plans to use the proceeds to advance the development of its drug candidates NXP800 and NXP900.

Related tickers: NVCT.

Read Full Article

Nuvectis Pharma, Inc. reported its Q3 2024 financial results and provided updates on the development of its drug candidates NXP800 and NXP900. The company expects a clinical data update for NXP800 this month and has progressed the NXP900 Phase 1a study with no dose-limiting toxicities.

Related tickers: NVCT.

Read Full Article
Trending Tickers

Please sign in to view